Clinical features of patients with B-CLL and transduction efficiency into primary CLL cells by AAV/EGFP and AAV/CD40L
| Patient . | Stage (Binet) . | Sex/age . | EGFP (%) . | EGFP (MFIR) . | CD40L (%) . | CD40L (MFIR) . |
|---|---|---|---|---|---|---|
| 1 | C | M/53 | 13.5 | 6.0 | ND | ND |
| 2 | A | F/56 | 15.5 | 3.6 | ND | ND |
| 3 | C | M/83 | 13.0 | 4.3 | ND | ND |
| 4 | A | M/61 | 42.4 | 5.3 | 77.8 | 209.0 |
| 5 | A | M/73 | 44.9 | 6.6 | 97.7 | 312.2 |
| 6 | A | M/64 | 41.0 | 8.4 | 15.0 | 2.5 |
| 7 | A | F/59 | 36.5 | 6.0 | 15.0 | 3.7 |
| 8 | A | F/65 | 24.5 | 3.4 | ND | ND |
| 9 | C | M/62 | 14.0 | 2.0 | ND | ND |
| 10 | C | M/64 | ND | ND | 13.4 | 3.0 |
| 11 | C | M/70 | 13.4 | 2.7 | 10.0 | 1.3 |
| 12 | A | M/53 | 16.0 | 2.6 | 48.0 | 19.3 |
| 13 | B | M/75 | ND | ND | 34.4 | 3.0 |
| 14 | C | M/57 | 28.0 | 4.7 | 31.8 | 3.5 |
| 15 | C | M/73 | ND | ND | 23.3 | 2.7 |
| 16 | B | M/53 | ND | ND | 45.5 | 11.4 |
| 17 | A | M/72 | 34.7 | 3.6 | ND | ND |
| 18 | B | F/63 | 41.4 | 5.2 | ND | ND |
| 19 | A | F/60 | 18.6 | 2.1 | ND | ND |
| 20 | A | M/46 | 34.0 | 3.7 | ND | ND |
| 21 | C | M/62 | 50.3 | 5.4 | 78.9 | 80.2 |
| 22 | B | M/70 | 63.0 | 15.2 | 81.5 | 164.9 |
| 23 | C | M/60 | ND | ND | 30.6 | 6.6 |
| 24 | C | M/41 | ND | ND | 56.6 | 14.0 |
| Patient . | Stage (Binet) . | Sex/age . | EGFP (%) . | EGFP (MFIR) . | CD40L (%) . | CD40L (MFIR) . |
|---|---|---|---|---|---|---|
| 1 | C | M/53 | 13.5 | 6.0 | ND | ND |
| 2 | A | F/56 | 15.5 | 3.6 | ND | ND |
| 3 | C | M/83 | 13.0 | 4.3 | ND | ND |
| 4 | A | M/61 | 42.4 | 5.3 | 77.8 | 209.0 |
| 5 | A | M/73 | 44.9 | 6.6 | 97.7 | 312.2 |
| 6 | A | M/64 | 41.0 | 8.4 | 15.0 | 2.5 |
| 7 | A | F/59 | 36.5 | 6.0 | 15.0 | 3.7 |
| 8 | A | F/65 | 24.5 | 3.4 | ND | ND |
| 9 | C | M/62 | 14.0 | 2.0 | ND | ND |
| 10 | C | M/64 | ND | ND | 13.4 | 3.0 |
| 11 | C | M/70 | 13.4 | 2.7 | 10.0 | 1.3 |
| 12 | A | M/53 | 16.0 | 2.6 | 48.0 | 19.3 |
| 13 | B | M/75 | ND | ND | 34.4 | 3.0 |
| 14 | C | M/57 | 28.0 | 4.7 | 31.8 | 3.5 |
| 15 | C | M/73 | ND | ND | 23.3 | 2.7 |
| 16 | B | M/53 | ND | ND | 45.5 | 11.4 |
| 17 | A | M/72 | 34.7 | 3.6 | ND | ND |
| 18 | B | F/63 | 41.4 | 5.2 | ND | ND |
| 19 | A | F/60 | 18.6 | 2.1 | ND | ND |
| 20 | A | M/46 | 34.0 | 3.7 | ND | ND |
| 21 | C | M/62 | 50.3 | 5.4 | 78.9 | 80.2 |
| 22 | B | M/70 | 63.0 | 15.2 | 81.5 | 164.9 |
| 23 | C | M/60 | ND | ND | 30.6 | 6.6 |
| 24 | C | M/41 | ND | ND | 56.6 | 14.0 |
ND indicates not determined.